| Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes W Robinson, JK Stone, F Schischlik, B Gasmi, MC Kelly, C Seibert, ... Science Advances 10 (27), eadj7402, 2024 | | 2024 |
| A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics DT Hoang, G Dinstag, ED Shulman, LC Hermida, DS Ben-Zvi, E Elis, ... Nature Cancer, 1-13, 2024 | | 2024 |
| The expression patterns of different cell types and their interactions in the tumor microenvironment are predictive of breast cancer patient response to neoadjuvant chemotherapy E Ruppin, SR Dhruba, S Sahni, B Wang, D Wu, P Rajagopal, ... | | 2024 |
| Decoupling the correlation between cytotoxic and exhausted T lymphocyte states enhances melanoma immunotherapy response prediction B Wang, K Wang, D Wu, S Sahni, P Jiang, E Ruppin Iscience 27 (6), 2024 | | 2024 |
| Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ... Nature, 1-1, 2024 | | 2024 |
| Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities P Desai, N Takahashi, R Kumar, S Nichols, J Malin, A Hunt, C Schultz, ... Cell Reports Medicine 5 (6), 2024 | | 2024 |
| ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response LQJ Lim, L Adler, E Hajaj, LR Soria, RBT Perry, N Darzi, R Brody, N Furth, ... Nature metabolism, 1-16, 2024 | 1 | 2024 |
| LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features TG Chang, Y Cao, HJ Sfreddo, SR Dhruba, SH Lee, C Valero, SK Yoo, ... Nature Cancer, 1-18, 2024 | | 2024 |
| Transcriptome-based response predictor to identify potential responders among patients with negative standard markers for response to immune checkpoint blockers. G Dinstag, E Elis, DS Ben-Zvi, A Elia, PS Rajagopal, KD Aldape, ... Journal of Clinical Oncology 42 (16_suppl), 2666-2666, 2024 | | 2024 |
| Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning DT Hoang, ED Shulman, R Turakulov, Z Abdullaev, O Singh, ... Nature Medicine, 1-10, 2024 | | 2024 |
| Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-specific Transcriptome and Molecular Subtype V Bahrambeigi, JJ Lee, V Branchi, KI Rajapakshe, Z Xu, N Kui, JT Henry, ... Cancer Research 84 (10), 1719-1732, 2024 | | 2024 |
| Anti-tetanus vaccination is associated with reduced occurrence and slower progression of Parkinson’s disease A Israel, E Magen, E Merzon, E Ruppin, S Vinker, N Giladi medRxiv, 2024.05. 03.24306800, 2024 | | 2024 |
| Programming a Ferroptosis‐to‐Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy (Adv. Sci. 17/2024) Y Vinik, A Maimon, V Dubey, H Raj, I Abramovitch, S Malitsky, M Itkin, ... Advanced Science 11 (17), 2024 | | 2024 |
| Programming a Ferroptosis‐to‐Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy Y Vinik, A Maimon, V Dubey, H Raj, I Abramovitch, S Malitsky, M Itkin, ... Advanced Science 11 (17), 2307263, 2024 | 3 | 2024 |
| PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors S Sinha, R Vegesna, S Mukherjee, AV Kammula, SR Dhruba, W Wu, ... Nature Cancer, 1-15, 2024 | | 2024 |
| Abstract LB002: Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to immune checkpoint blockade S Sahni, B Wang, D Wu, SR Dhruba, M Nagy, S Patkar, I Ferreira, K Wang, ... Cancer Research 84 (7_Supplement), LB002-LB002, 2024 | | 2024 |
| Abstract LB250: Dynamics of transcript alternations and differential splicing in the evolution of acquired MAPKi resistance in melanoma S Mukherjee, A Singh, H Joo, S Patiyal, H Kim, LR Pal, K Wang, CP Day, ... Cancer Research 84 (7_Supplement), LB250-LB250, 2024 | | 2024 |
| Abstract LB007: A systematic evaluation of the therapeutic potential of Endogenous-ADAR base editors in cancer prevention and treatment R Merdler-Rabinowicz, A Dadush, S Patiyal, PS Rajagopal, G Daya, ... Cancer Research 84 (7_Supplement), LB007-LB007, 2024 | | 2024 |
| Abstract LB245: Single cell guided identification of logic-gated cell surface combinations for selective and safe CAR therapy design S Madan, T Chang, B Wang, SR Dhruba, AA Schäffer, E Ruppin Cancer Research 84 (7_Supplement), LB245-LB245, 2024 | | 2024 |
| Abstract LB242: Prediction of patient response to neoadjuvant chemotherapy in breast cancer from their deconvolved tumor microenvironment transcriptome SR Dhruba, S Sahni, B Wang, D Wu, Y Schmidt, E Shulman, S Sinha, ... Cancer Research 84 (7_Supplement), LB242-LB242, 2024 | | 2024 |
Roded SharanTel Aviv University在 post.tau.ac.il 的电子邮件经过验证
